All News #Library
Others
Cadrenal Therapeutics Acquires eXIthera’s Factor XIa Inhibitors
15 Sep 2025 //
GLOBENEWSWIRE
eXIthera Announces FDA Acceptance of IND Application for Ph2 Trial of EP-7041
03 Mar 2021 //
PRNEWSWIRE

Market Place
Sourcing Support